Top Stock Movers Now: Broadcom, Micron Technology, Supermicro, Ford, and More
The Nasdaq climbed to a fresh high Monday as tech stocks gained ahead of an expected decision on interest rates from the Federal Reserve later this week.
The Nasdaq climbed to a fresh high Monday as tech stocks gained ahead of an expected decision on interest rates from the Federal Reserve later this week.
On Monday, Larimar Therapeutics, Inc. (NASDAQ:LRMR) released initial data from the ongoing long-term OLE study evaluating daily subcutaneous injections of 25 mg of nomlabofusp self-administered or administered by a caregiver in participants with Friedreich’s Ataxia. Friedreich’s Ataxia is caused by a mutation in the FXN gene, which carries the code for the frataxin protein. Frataxin is important for the normal function of mitochondria, the energy-producing parts of cells At the time of data cut
IPO Edge hosted a fireside chat on Dec. 10 at Nasdaq MarketSite with J.D. Moriarty, Chief Executive Officer of ICR Capital. The in-person interview was joined by Editor-in-Chief John Jannarone and they […]
As adoption accelerates, new price targets emerge, reflecting growing consumer interest and significant future investments.
Americans hoping for lower borrowing costs for homes, credit cards and cars may be disappointed after this week's Federal Reserve meeting. The Fed's policymakers are likely to signal fewer interest rate cuts next year than were previously expected. The officials are set to reduce their benchmark rate, which affects many consumer and business loans, by a quarter-point to about 4.3% when their meeting ends Wednesday.
Bitcoin ATMs and adoption hurdles raise questions about the cryptocurrency's impact on financial inclusion.
From financial tools to global mining, Bitcoin continues transforming markets amid growing demand and innovation.
Balancing convenience and self-custody, this technology empowers individuals while institutions leverage promising new revenue opportunities.
Bristol Myers Squibb’s Cobenfy is the first treatment in seven decades that does not modulate dopaminergic or serotonergic transmission.
Oppenheimer boosted Netflix's price target, pointing to the benefits of the biggest streaming service's live events.